Potentiation of Isoniazid Activity againstMycobacterium tuberculosisby Melatonin
Author(s) -
Ian Wiid,
Eileen G. Hoal,
Dinie Hon,
Carl Lombard,
Paul D. van Helden
Publication year - 1999
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.43.4.975
Subject(s) - isoniazid , melatonin , tuberculosis , mycobacterium tuberculosis , long term potentiation , medicine , pharmacology , immunology , biology , pathology , receptor
The limited number of effective antituberculosis drugs available necessitates optimizing current treatments. We show that melatonin, which is synthesized in the pineal gland, can cause at least a threefold increase in the efficacy of isoniazid. This suggests that tuberculosis chemotherapy can be improved by innate molecules such as melatonin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom